By Jason Lange and Julie Steenhuysen WASHINGTON (Reuters) -Americans worry about the Trump administration's ability to ...

Q1 2025 Earnings Call Transcript May 13, 2025 Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) ...

When the Covid-19 pandemic hit, the then-Stanford professor was one of the loudest critics of lockdowns, school closures and ...

WASHINGTON (Reuters) - Americans worry about President Donald Trump's administration's ability to contain an ongoing outbreak ...

The global cholesterol API market is witnessing robust growth, driven by the expanding application of cholesterol-based raw materials across pharmaceuticals, biotechnology, cosmetics, and advanced ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

Actively screening for the 10,000 participant portion of COVID-19 Phase 2b trial; Dosing expected to begin in second quarter of 2025 Completed enrollment of Phase 1 clinical trial evaluating Company’s ...

LANSING— Mistrust in government had a bigger impact on COVID-19 vaccine hesitancy than medical mistrust among African Americans in Southeast Michigan, according to a recent study. Led by Mark Manning, ...

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73 (95% confidence interval, 0.56 to 0.96) compared to ...

In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...